Latigo Biotherapeutics (LTGO) prices $345.6 million IPO at $18 a share
One daysingle sourceOne outlet reported this, once - no second voice in this corpus.
After publishing: 1 headline quietly rewritten1 change
- 247wallst.comseen 15 Aug, 03:07headline rewritten
Latigo priced its IPO at $18 a share for $345.6 million, one of the largest biotech raises of the year and…Latigo Biotherapeutics (LTGO) prices $345.6 million IPO at $18 a share
All 1 reports on Fri, 7 August 2026
What it is about
Who published it, and when
How it spread - 1 original report
Fri, 7 August 2026
1 report- 247wallst.com20:24first to reportedited after publishing
previously
Latigo priced its IPO at $18 a share for $345.6 million, one of the largest biotech raises of the year and…Latigo priced its IPO at $18 a share for $345.6 million, one of the largest biotech raises of the year and enough capital to push its non-opioid painkiller against Vertex's head start. Goldman Sachs,…